18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation

• Status: Recruiting
• Trial end date: 2023-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using 18F-FSPG PET/MRI.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Collaborator: GE Healthcare

Criteria

Inclusion Criteria:

• Patient is ≥ 18 years old at the time of the scan

• Patient with known or suspected cardiac sarcoidosis.

• Patient is capable of complying with study procedures

• Patient can remain still for duration of imaging procedure

Exclusion Criteria:

• Patient is pregnant or nursing

• Metallic implants (contraindicated for MRI)

• History of renal insufficiency (only for MRI contrast administration)